Sabina Birgitte Larsen
YOU?
Author Swipe
View article: Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments
Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments Open
View article: Transfer of modified gut viromes improves symptoms associated with metabolic syndrome in obese male mice
Transfer of modified gut viromes improves symptoms associated with metabolic syndrome in obese male mice Open
View article: Transfer of modified fecal viromes improve blood glucose regulation and alleviates symptoms of metabolic dysfunction-associated fatty liver disease in an obesity male mouse model
Transfer of modified fecal viromes improve blood glucose regulation and alleviates symptoms of metabolic dysfunction-associated fatty liver disease in an obesity male mouse model Open
Metabolic syndrome encompasses amongst other conditions like obesity, type-2 diabetes, and metabolic dysfunction associated fatty liver disease (MAFLD), which are all associated with gut microbiome (GM) dysbiosis. Fecal microbiota transpla…
View article: Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments
Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments Open
Background Fecal microbiota transplantation (FMT) and fecal virome transplantation (FVT, sterile filtrated donor feces) have been effective in treating recurrent Clostridioides difficile infections, possibly through bacteriophage-mediated …